Related references
Note: Only part of the references are listed.Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses
Ville Harma et al.
PLOS ONE (2010)
Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen
U. Elsaesser-Beile et al.
CURRENT DRUG TARGETS (2009)
A Duplex Quantitative Polymerase Chain Reaction Assay Based on Quantification of α-Methylacyl-CoA Racemase Transcripts and Prostate Cancer Antigen 3 in Urine Sediments Improved Diagnostic Accuracy for Prostate Cancer
Bin Ouyang et al.
JOURNAL OF UROLOGY (2009)
The use of PCA3 in the diagnosis of prostate cancer
Daphne Hessels et al.
NATURE REVIEWS UROLOGY (2009)
Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)
Stacy Loeb et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
Bharathi Laxman et al.
CANCER RESEARCH (2008)
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
Outi R. Saramaki et al.
CLINICAL CANCER RESEARCH (2008)
Development of a multiplexed urine assay for prostate cancer diagnosis
Tatiana Vener et al.
CLINICAL CHEMISTRY (2008)
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Alexander Haese et al.
EUROPEAN UROLOGY (2008)
Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
Margaret S. Pepe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer
Daphne Hessels et al.
CLINICAL CANCER RESEARCH (2007)
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy
Leonard S. Marks et al.
UROLOGY (2007)
The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a dutch multicenter validation of the diagnostic performance
Martijn P. M. Q. van Gils et al.
CLINICAL CANCER RESEARCH (2007)
Quantitative multi-gene expression profiling of primary prostate cancer
Uta Schmidt et al.
PROSTATE (2006)
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer
Bharathi Laxman et al.
NEOPLASIA (2006)
Quantitative expression profile of PSGR in prostate cancer
LL Xu et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
The Vienna nomogram: Validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume
M Remzi et al.
JOURNAL OF UROLOGY (2005)
Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects
MO Hoque et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Use of multiple biomarkers for a molecular diagnosis of prostate cancer
KA Landers et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A Ghosh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Combining biomarkers to detect disease with application to prostate cancer
R Etzioni et al.
BIOSTATISTICS (2003)
DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer
D Hessels et al.
EUROPEAN UROLOGY (2003)
Repeat prostate biopsy: Who, how and when? A review
B Djavan et al.
EUROPEAN UROLOGY (2002)
Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis
EW Steyerberg et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Identifying combinations of cancer markers for further study as triggers of early intervention
SG Baker
BIOMETRICS (2000)